Human natural killer cells split into two principal subsets defined by the surface marker CD56: CD56bright cells, which are prolific producers of immune-signaling molecules like interferon-gamma, and CD56dim cells, which specialize in directly killing virus-infected or cancerous cells. That two-subset framework has guided immunology for decades, but the real picture is considerably richer. Tissue-resident populations, “memory-like” adaptive cells, and recently identified subgroups revealed by single-cell sequencing have all complicated the old bright-versus-dim binary in ways that matter for cancer therapy, pregnancy, autoimmune disease, and aging.
CD56bright and CD56dim in the Blood
When researchers draw a blood sample and sort NK cells, roughly 90 percent fall into the CD56dim pool and only about 10 percent are CD56bright. That ratio can mislead, though, because CD56bright cells actually outnumber their dim counterparts across the whole body once you count the cells residing in lymph nodes, the liver, the uterus, and other tissues.1PubMed Central. Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations Blood-based studies therefore give a skewed impression of how these subsets are distributed.
The functional split between the two subsets is sometimes described as “regulators versus killers.” CD56bright cells are potent producers of interferon-gamma (IFN-γ), and their higher metabolic activity supports that cytokine output during an immune response.2The Journal of Immunology. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells CD56dim cells, by contrast, carry larger stores of cytotoxic granules and express CD16, the receptor that lets them recognize antibody-coated target cells and destroy them through a process called antibody-dependent cellular cytotoxicity. When CD56dim cells are depleted or dysfunctional, this antibody-mediated killing drops off measurably. Research in Hodgkin lymphoma patients, for example, found that a lower frequency of CD56dim CD16+ cells translated into impaired degranulation against antibody-coated targets.3PubMed Central. Reduced frequency of cytotoxic CD56(dim) CD16(+) NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
The surface receptor profiles of the two subsets diverge in ways that dictate where each one migrates in the body. CD56bright cells express the chemokine receptor CCR7 and the adhesion molecule L-selectin (CD62L), which steer them toward secondary lymphoid organs like lymph nodes. CD56dim cells instead express CXCR1 and CX3CR1, which pull them toward sites of acute inflammation. The inhibitory receptor landscape is also different: CD56bright cells uniformly express CD94/NKG2A at high density but lack the killer immunoglobulin-like receptors (KIRs) found on varying proportions of CD56dim cells. And only the bright subset carries the high-affinity receptor for interleukin-2, allowing these cells to proliferate vigorously even at very low concentrations of that growth signal.4PubMed Central. CD56bright natural killer (NK) cells: an important NK cell subset
A Developmental Continuum, Not a Hard Divide
The bright-versus-dim distinction suggests two fixed categories, but the current evidence points to a maturation continuum. CD56bright cells appear to be the less mature precursors that progressively differentiate into CD56dim cells. A key piece of evidence for this comes from tracking the surface molecule CD94: CD56dim cells with high CD94 expression look functionally more like CD56bright cells than like their low-CD94 dim counterparts, placing them as an intermediary stage on the maturation path. The data support a model in which NK cells move through a continuous spectrum from CD56bright through CD94-high CD56dim, ending at a fully mature CD94-low CD56dim phenotype.5PubMed Central. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets
Maturation does not stop once a cell reaches the CD56dim stage. These cells continue to differentiate, progressively acquiring surface markers like KIRs and CD57 while losing NKG2A. That ongoing specialization was once overlooked because researchers assumed CD56dim cells were a single stable endpoint. In reality, the sequential expression patterns of NKG2A, KIR, and CD57 map out further stages of differentiation within the dim compartment itself.6PubMed. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education The practical upshot is that two CD56dim cells sitting side by side may have very different histories and very different functional capacities.
Adding further nuance, the NK cell repertoire is maintained partly through intra-lineage plasticity. During routine homeostatic turnover driven by IL-15, slowly dividing KIR-positive CD56dim cells can acquire a CD57-positive phenotype with enhanced functional potential, while rapidly cycling cells upregulate NKG2A and lose functionality. The system balances these shifts to preserve the overall diversity of the repertoire.7Cell Reports. Intra-lineage Plasticity Maintains Phenotypic and Functional NK Cell Homeostasis
Tissue-Resident NK Cells
Not every NK cell patrols the bloodstream. Populations of tissue-resident NK cells have been identified in the lungs, liver, uterus, and lymphoid organs, and these cells look and behave differently from anything found in circulation. In human lung tissue, for instance, resident NK cells expressing the markers CD69 and CD49a share a gene-expression signature with tissue-resident memory T cells, including upregulation of retention-associated genes and downregulation of genes that promote exit into the bloodstream.8Nature Communications. Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells These cells appear to be committed sentinels that stay put rather than recirculating.
Mouse models have shown that circulating NK cells can be recruited to the skin during an acute infection and then differentiate into tissue-resident cells on site. These newly resident cells share transcriptional similarity with CD56bright TCF1-high NK cells found in human tissues, and they mediate faster responses to a second infection in the same location.9PubMed Central. Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection That ability to settle into tissues and provide local immune memory blurs the boundary between innate and adaptive immunity.
Tissue context also shapes the phenotype of CD56bright cells. In the uterus, resident CD56bright NK cells express CD49a; in the liver and lymphoid tissues, they co-express CD69 and CXCR6. These aren’t just trivial surface-marker differences. They reflect distinct functional programs tailored to each organ’s needs.1PubMed Central. Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
Uterine NK Cells and Pregnancy
One of the most striking examples of tissue-specific NK cell function is in the uterus during early pregnancy. Uterine NK cells (often abbreviated uNK) are the dominant immune cell in the lining of the uterus after implantation. Rather than killing anything, these cells secrete angiogenic growth factors that help remodel the spiral arteries feeding the placenta. In experimental models, uNK cell secretions disrupted the smooth-muscle layer of blood vessels and broke down surrounding structural proteins, consistent with the early phases of spiral artery remodeling needed for healthy placental blood flow.10PubMed. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy
When NK cells are depleted in mouse models, pro-angiogenic factor delivery drops and spiral artery development stalls, which lowers oxygen tension at the placentation site and redirects the behavior of placental cells toward a more invasive phenotype.11PubMed Central. Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions This suggests that uNK cells don’t just passively accompany pregnancy; they actively direct how the placenta forms. Failure of this process has been linked to pregnancy complications like pre-eclampsia, making uterine NK cell biology a focus of ongoing reproductive immunology research.
Adaptive and Memory-Like NK Cells
NK cells were long considered purely innate, meaning they responded the same way to every encounter without learning from past infections. That assumption has been overturned. In people who have been infected with cytomegalovirus (CMV), a subset of NK cells expressing the activating receptor NKG2C expands and persists long-term. These cells also co-express CD57, a marker associated with terminal maturation, and they preferentially lose the inhibitory receptor NKG2A. During active CMV infection, the proportion of these CD57-positive NKG2C-high NK cells increases further, and they degranulate efficiently when their NKG2C receptor is triggered, behaving much like memory T cells recognizing a familiar threat.12PubMed Central. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
The story gets more interesting in people who lack NKG2C entirely. Even in these individuals, CMV infection still drives the generation of adaptive NK cells, apparently through alternative co-stimulatory receptors like CD2. This means the adaptive NK cell phenomenon is broader than any single receptor.13PubMed Central. Human Adaptive Natural Killer Cells: Beyond NKG2C At the molecular level, adaptive NK cells are marked by the silencing of certain signaling proteins (FcεRIγ, SYK, and EAT-2) through epigenetic changes. Promoter regions of the genes encoding these proteins become heavily methylated, permanently shutting them off. This epigenetic reprogramming appears to be a hallmark of adaptive differentiation and can be used to identify these cells reliably across donors.14Immunity. Adaptive NK Cells Can Be Recognized by Standardization of FcεRγ, SYK, and EAT-2 and Reduced PLZF Expression
A separate form of NK cell memory can be generated artificially by briefly exposing cells to a cocktail of IL-12, IL-15, and IL-18. These cytokine-induced memory-like (CIML) NK cells show enhanced effector function for weeks to months afterward, even without continued cytokine exposure.15PubMed Central. Human Cytokine-Induced Memory-Like Natural Killer Cells In laboratory studies, CIML NK cells displayed stronger IFN-γ production and greater cytotoxicity against acute myeloid leukemia cells compared to conventional NK cells.16PubMed Central. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia This finding has pushed CIML NK cells into clinical trials as a potential leukemia treatment.
NK Cell Education and Self-Tolerance
Before any NK cell can function properly, it goes through an education process that calibrates how reactive it will be. The basic idea is that NK cells carrying inhibitory receptors that match the body’s own MHC class I molecules get “licensed” to respond strongly, while NK cells lacking a matching inhibitory receptor remain present but functionally dampened. Research has confirmed that NK cells in human blood that lack inhibitory KIRs for self-MHC class I look phenotypically mature but respond weakly to stimulation, including against target cells that have lost their MHC molecules entirely.17PubMed. Human NK cell education by inhibitory receptors for MHC class I
Several models have been proposed to explain this calibration. The “licensing” or “arming” model holds that interaction with self-MHC switches on the cell’s killing potential. The “disarming” model says that cells chronically stimulated without inhibitory feedback turn themselves down. The “tuning” model frames it as a rheostat rather than an on-off switch, with cells adjusting their sensitivity according to the cumulative inhibitory input they receive.18PubMed Central. Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned Education is relevant for therapy because it means not all NK cells in a donor are equally effective. A cell’s receptor-ligand match with a patient’s tissues can determine whether it will fight tumors aggressively or sit idle.
How Aging Shifts the NK Cell Landscape
As people age, the composition of NK cell subsets shifts noticeably. The CD56bright population shrinks, while an unusual CD56-negative CD16-positive population expands. Total NK cell numbers tend to rise with age, but this numerical increase masks a functional decline: older adults’ NK cells produce fewer cytokines and kill target cells less efficiently.19PubMed Central. Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions
Disentangling aging from CMV exposure is tricky, because most older adults have been infected with CMV at some point. Research comparing these two influences found that the redistribution of NK cell subsets (the drop in CD56bright cells, the rise of CD56-negative cells) tracks with age itself rather than CMV status. However, the accumulation of CD57-positive long-lived NK cells within the CD56dim compartment is driven by CMV and can be seen even in young CMV-positive individuals.20PubMed. Shaping of NK cell subsets by aging This distinction matters clinically because it means some age-related NK changes are inherent to immune senescence while others are scars of past infections.
NK Cells in Autoimmune Disease
NK cells are not purely protective. In autoimmune conditions, they can act as a double-edged sword. Their cytotoxic activity and cytokine output contribute to the pathology of diseases like rheumatoid arthritis, lupus, ankylosing spondylitis, multiple sclerosis, and psoriasis.21PubMed Central. The Role of Natural Killer Cells in Autoimmune Diseases Yet in some contexts, NK cells also play a regulatory role, dampening other immune cells and helping to resolve inflammation.
Whether NK cells push disease forward or hold it back appears to depend on which subset dominates, the tissue microenvironment, and the phase of the disease. The same cell type can switch between harmful and protective depending on these contextual signals.22PubMed. NK cells – Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases The precise mechanisms behind these opposing roles are still being worked out, but the emerging picture suggests that different NK subsets tilt the balance in different directions, and that blanket suppression of NK cells in autoimmune patients could backfire by removing both the harmful and the protective arms simultaneously.23PubMed. NK cell subsets in autoimmune diseases
Tumors and Viral Infections Push NK Cells Toward Exhaustion
In healthy tissue, NK cells patrol effectively. Inside solid tumors, however, they frequently become exhausted, losing their ability to kill and to produce cytokines. The tumor microenvironment uses multiple strategies to wear NK cells down, including suppressive signaling molecules, nutrient competition, and physical barriers that limit cell-to-cell contact.24PubMed Central. NK cell exhaustion in the tumor microenvironment Understanding which NK subsets are most vulnerable to exhaustion and which resist it is an active area of cancer immunology research.
Viral infections similarly reshape the NK cell compartment, altering subset frequencies, relocating cells to infected tissues, and sometimes driving dysfunction. These shifts during viral challenge are subset-specific and can persist beyond the acute infection, leaving lasting imprints on the NK cell repertoire.25PubMed Central. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics? The adaptive NK cells described earlier are one example of a lasting imprint: CMV infection permanently expands a distinct subset with unique functional properties.
Beyond the Two-Subset Framework
High-dimensional single-cell technologies have started to reveal that even the bright-dim-adaptive taxonomy is a simplification. A 2024 study using single-cell RNA sequencing and combined protein-and-transcript profiling identified three prominent NK cell subsets in healthy human blood, designated NK1, NK2, and NK3, which further subdivide into six distinct subgroups. Each subgroup had its own transcription factor profile, metabolic traits, and cytokine response patterns.26PubMed Central. High-dimensional single-cell analysis of human natural killer cell heterogeneity The old CD56 bright-versus-dim categories don’t disappear in this new framework, but they become the broadest strokes of a much more detailed picture. As these deeper classification systems gain traction, they may eventually change how clinicians select NK cells for therapy or predict which patients will respond to NK-cell-based treatments.
Comparative biology adds another layer. Single-cell sequencing of chicken NK cells identified NK-1 and NK-2 subsets analogous to mammalian populations, though with enormous gene-expression divergence. Thousands of genes were differentially expressed between chicken and human NK subsets, with the differences being especially pronounced in the NK-1 population.27iScience. Single-cell RNA sequencing reveals evolutionarily conserved natural killer cell subsets in chickens The fact that the basic split into functionally distinct NK subsets has been conserved across hundreds of millions of years of evolution, despite massive species-level differences in the specific genes involved, hints at how fundamental the division of labor between cytokine-producing and cytotoxic NK cells really is.
Therapeutic Frontiers Using Engineered NK Subsets
The growing understanding of NK cell diversity is feeding directly into cell therapy. One major advantage of NK cells over T cells for off-the-shelf immunotherapy is that NK cells do not require HLA matching with the patient and do not cause graft-versus-host disease. This makes them candidates for treatments that can be manufactured in advance from unrelated donors or, increasingly, from induced pluripotent stem cells (iPSCs).28PubMed Central. CAR-NK cells from engineered pluripotent stem cells: Off-the-shelf therapeutics for all patients.
iPSC-derived NK cells can be genetically engineered at the stem cell stage, for instance by inserting chimeric antigen receptors (CARs) that direct them against specific tumor targets. Because the engineering happens before the cells differentiate, every NK cell produced from a given iPSC line carries the same modification, allowing standardized manufacturing at scale.29PubMed Central. IPSC‑derived NK cells for immunotherapy and therapeutic perspective The challenge now is directing differentiation toward the NK subset with the right functional profile for a given clinical goal. For solid tumors, a heavily cytotoxic CD56dim-like cell loaded with a tumor-targeting CAR could be ideal. For leukemia, CIML NK cells with their enhanced IFN-γ output and sustained activation may fit better. Matching the subset to the disease is where NK cell biology meets clinical design, and it’s a frontier that’s moving fast.
Mouse NK Subsets and Why They Don’t Map Neatly Onto Humans
Much of our mechanistic understanding of NK cells comes from mouse studies, but mice don’t use the same subset markers as humans. Instead of CD56, mouse NK cells are classified by the surface molecules CD27 and CD11b, which define a four-stage maturation program. The sequence runs from CD11b-low CD27-low (least mature) through CD11b-low CD27-high and CD11b-high CD27-high to CD11b-high CD27-low (most mature and most cytotoxic).30PubMed. Maturation of mouse NK cells is a 4-stage developmental program The functional parallels to the human bright-to-dim continuum are real, with less mature mouse NK cells being better cytokine producers and more mature ones being better killers, but the molecular details are different enough that findings from mouse models don’t always translate directly. Researchers working on NK-based therapies need to validate in human cells any insight first observed in mice, which is part of why clinical progress has been slower than the preclinical enthusiasm might suggest.